Literature DB >> 19938313

FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19938313

Source DB:  PubMed          Journal:  AIDS Alert        ISSN： 0887-0292


× No keyword cloud information.
  8 in total

1.  Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.

Authors:  Mathieu Métifiot; Kasthuraiah Maddali; Alena Naumova; Xuemin Zhang; Christophe Marchand; Yves Pommier
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

2.  Potential benefit of dolutegravir once daily: efficacy and safety.

Authors:  Alessandra Fantauzzi; Ombretta Turriziani; Ivano Mezzaroma
Journal:  HIV AIDS (Auckl)       Date:  2013-02-07

3.  Resistance to integrase inhibitors.

Authors:  Mathieu Métifiot; Christophe Marchand; Kasthuraiah Maddali; Yves Pommier
Journal:  Viruses       Date:  2010-06-25       Impact factor: 5.048

Review 4.  Novel therapeutic strategies targeting HIV integrase.

Authors:  Peter K Quashie; Richard D Sloan; Mark A Wainberg
Journal:  BMC Med       Date:  2012-04-12       Impact factor: 8.775

5.  Novel 3'-Processing Integrase Activity Assay by Real-Time PCR for Screening and Identification of HIV-1 Integrase Inhibitors.

Authors:  Supachai Sakkhachornphop; Weeraya Thongkum; Chatchai Tayapiwatana
Journal:  Biomed Res Int       Date:  2015-05-07       Impact factor: 3.411

6.  Molecular features related to HIV integrase inhibition obtained from structure- and ligand-based approaches.

Authors:  Luciana L de Carvalho; Vinícius G Maltarollo; Emmanuela Ferreira de Lima; Karen C Weber; Kathia M Honorio; Albérico B F da Silva
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 7.  HIV drug resistance against strand transfer integrase inhibitors.

Authors:  Kaitlin Anstett; Bluma Brenner; Thibault Mesplede; Mark A Wainberg
Journal:  Retrovirology       Date:  2017-06-05       Impact factor: 4.602

8.  Micronucleated erythrocytes in newborn rats exposed to raltegravir placental transfer.

Authors:  Blanca Miriam Torres-Mendoza; Damharis Elizabeth Coronado-Medina; Belinda Claudia Gómez-Meda; Eduardo Vázquez-Valls; Ana Lourdes Zamora-Perez; María de Lourdes Lemus-Varela; Guillermo Moisés Zúñiga-González
Journal:  Biomed Res Int       Date:  2014-05-25       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.